Société Adverum Biotechnologies, Inc.
Actions
ADVM
US00773U2078
Recherche biotechnologique et médicale
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
10,06 USD | -1,23 % | -10,22 % | +35,36 % |
Métier
Nombre d'employés: 121
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Gene Therapeutics
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15/06/20 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 12/12/22 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Romuald Corbau
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/01 |
Peter Soparkar
COO | Chief Operating Officer | 53 | 30/10/19 |
R. Ramelmeier
CTO | Chief Tech/Sci/R&D Officer | 62 | 21/08/23 |
Anand Reddi
HRO | Human Resources Officer | 42 | - |
Star Seyedkazemi
PRN | Corporate Officer/Principal | 50 | 06/01/22 |
Corporate Officer/Principal | - | 25/06/20 | |
Dena House
HRO | Human Resources Officer | - | 01/07/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 64 | 16/04/20 | |
Clarence Machado
CHM | Chairman | 60 | 14/03/17 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15/06/20 |
Jim Scopa
BRD | Director/Board Member | 65 | 01/05/19 |
C. Nicholson
BRD | Director/Board Member | 68 | 03/11 |
Mark Lupher
BRD | Director/Board Member | 53 | 01/05/19 |
Reed Tuckson
BRD | Director/Board Member | 73 | 19/02/21 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 09/12/20 |
Rabia Ozden
BRD | Director/Board Member | 56 | 17/03/22 |
Soo Hong
BRD | Director/Board Member | 52 | 17/03/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 20 754 915 | 20 327 441 ( 97,94 %) | 0 | 97,94 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+35,36 % | 211 M | |
-1,51 % | 104 Md | |
+3,22 % | 97,42 Md | |
+0,17 % | 22,2 Md | |
-16,53 % | 21,23 Md | |
-10,44 % | 18,33 Md | |
-42,33 % | 16,35 Md | |
-20,09 % | 15,06 Md | |
+5,47 % | 13,98 Md | |
+28,85 % | 11,66 Md |
- Bourse
- Actions
- Action ADVM
- Société Adverum Biotechnologies, Inc.